[1]高璐,信中,袁明霞,等.代谢综合征与糖尿病及糖尿病前期人群 糖尿病视网膜病变的相关性分析[J].国际内分泌代谢杂志,2017,37(05):298-302.
　Gao Lu*,Xin Zhong,Yuan Mingxia,et al.A study on correlation between metabolic syndrome and diabetic retinopathy in diabetic and pre-diabetic people[J].International Journal of Endocrinology and Metabolism,2017,37(05):298-302.
点击复制

代谢综合征与糖尿病及糖尿病前期人群 糖尿病视网膜病变的相关性分析()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
37
期数:
2017年05期
页码:
298-302
栏目:
论著
出版日期:
2017-09-20

文章信息/Info

Title:
A study on correlation between metabolic syndrome and diabetic retinopathy in diabetic and pre-diabetic people
作者:
高璐; 信中; 袁明霞; 曹曦; 冯建萍; 石敬; 朱晓蓉; 杨金奎; 秦明照
100730 首都医科大学附属北京同仁医院老年医学科/干部医疗科(高璐,秦明照),内分泌科(信中,袁明霞,曹曦,冯建萍,石敬,朱晓蓉,杨金奎)
Author(s):
Gao Lu*;  Xin Zhong;  Yuan Mingxia;  Cao Xi;  Feng Jianping;  Shi Jing;  Zhu Xiaorong;  Yang Jinkui;  Qin Mingzhao.
*Department of Geriatrics, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
关键词:
糖尿病;  糖尿病视网膜病变;  代谢综合征
Keywords:
Diabetes mellitus;  Diabetic retinopathy;  Metabolic syndrome
文献标志码:
A
摘要:
目的 研究糖尿病与糖尿病前期人群代谢综合征(MS)与糖尿病视网膜病变(DR)的相关性。方法 在北京市昌平区进行了一项有关慢性疾病和危险因素的健康调查,其中 2 551人完成了病史采集、体格检查、血脂、血糖等生化指标的测定和眼底检查。将受试对象分为DR组和无DR组(NDR组),将NDR组按HbA1c水平与DR组1:1进行匹配(NDR组及DR组各74例),进行病例对照研究。进一步将受试对象分为MS组(105例)和无MS组(NMS组,43例),而后进行两组罹患DR的比较分析。结果 DR组和NDR组各项临床和生化指标差异均无统计学意义。然而,罹患DR患者的比例按照符合MS组分个数的增加而呈线性增加(χ2=9.938,P=0.037)。MS组合并DR的比例明显高于无MS组(χ2=5.540,P=0.019)。调整了年龄、性别、腰围、收缩压、总胆固醇、HbA1c和糖尿病病程后,MS是DR的一个独立危险因素(OR=2.948,95% CI:1.134～7.664,P=0.027)。结论 在糖尿病及糖尿病前期人群中,MS与DR明显相关。即使在血糖控制水平一致的情况下,MS仍是DR的独立危险因素。
Abstract:
Objective To study the relationship between metabolic syndrome(MS)and diabetic retinopathy(DR)in diabetic and pre-diabetic people.Methods This was a survey on chronic diseases and their risk factors conducted in Changping, Beijing. A total of 2 551 subjects completed the medical history collection, physical examination, laboratory measurements of serum lipid, blood sugar and other biochemical indices, as well as the fundus checking. All subjects were divided into DR group and non-DR(NDR)group. NDR group was matched to DR group by HbA1c in 1:1 ratio. Therefore, 74 DR patients and 74 HbA1c-matched NDR subjects were included in this case control study. All subjects were further divided into MS group(105 subjects)or non-MS group(43 subjects)to analyze the incidence of DR.Results There were no statistical differences between DR group and NDR group in a number of biological or clinical markers. However, the percentage of patients with DR were increased along with the increase of MS constitutes(χ2=9.938, P=0.037). The percentage of patients combined with MS was significantly higher than that in patients without MS(χ2=5.540, P=0.019). MS was an independent risk factor of DR after adjusting for age, sex, waist circumference, systolic blood pressure, total cholesterol, HbA1c and duration of diabetes(OR=2.948, 95% CI: 1.134-7.664, P=0.027).Conclusion There is a significant correlation between MS and DR in diabetic and pre-diabetic people. MS is an independent risk factor of DR, even to the same extent of glycemic control.

参考文献/References:

[1] Nguyen TT, Wong TY. Retinal vascular manifestations of metabolic disorders[J].Trends Endocrinol Metab,2006,17(7):262-268.DOI:10.1016/j.tem.2006.07.006.
[2] Engelgau MM, Thompson TJ, Herman WH,et al. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited[J].Diabetes Care,1997,20(5):785-791.
[3] Wilkinson CP, Ferris FL 3rd, Klein RE,et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales[J].Ophthalmology,2003,110(9):1677-1682. DOI:10.1016/S0161-6420(03)00475-5.
[4] Zhou BF,Cooperative Meta-Analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults[J].Biomed Environ Sci,2002,15(1):83-96.
[5] Alberti KG, Eckel RH, Grundy SM,et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity[J].Circulation,2009,120(16):1640-165.DOI:10.1161/CIRCULATIONAHA.109.192644.
[6] Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J].Diabet Med,1998,15(7):539-553.DOI:10.1002/(SICI)1096-9136(199807)15:7<539:AID-DIA668>3.0.co; 2-S.
[7] American Diabetes Association. Diagnosis and classification of diabetes mellitus[J].Diabetes Care,2014,37(Suppl 1):S81-S90. DOI:10.2337/dc14-S081.
[8] Fong DS, Aiello L, Gardner TW,et al. Retinopathy in diabetes[J].Diabetes Care,2004,27(Suppl 1):S84-S87.
[9] Tabák AG, Herder C, Rathmann W,et al. Prediabetes: a high-risk state for diabetes development[J].Lancet,2012,379(9833):2279-2290. DOI:10.1016/S0140-6736(12)60283-9.
[10] Lamparter J, Raum P, Pfeiffer N,et al. Prevalence and associations of diabetic retinopathy in a large cohort of prediabetic subjects: the Gutenberg Health Study[J].J Diabetes Complications,2014,28(4):482-487. DOI:10.1016/j.jdiacomp.2014.02.008.
[11] Tuomilehto J, Lindström J, Eriksson JG,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance[J].N Engl J Med,2001,344(18):1343-1350.DOI:10.1056/nejm200105033441801.
[12] Chew EY, Davis MD, Danis RP,et al. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes(ACCORD)Eye Study[J].Ophthalmology,2014,121(12):2443-2451. DOI:10.1016/j.ophtha.2014.07.019.
[13] Metascreen Writing Committee, Bonadonna R, Cucinotta D,et al. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey[J].Diabetes Care,2006,29(12):2701-2707.DOI:10.2337/dc06-0942.
[14] Iwasaki T, Togashi Y, Ohshige K,et al. Neither the presence of metabolic syndrome as defined by the IDF guideline nor an increased waist circumference increased the risk of microvascular or macrovascular complications in Japanese patients with type 2 diabetes[J].Diabetes Res Clin Pract,2008,79(3):427-432. DOI:10.1016/j.diabres.2007.10.035.
[15] Reilly MP, Rader DJ. The metabolic syndrome: more than the sum of its parts [J].Circulation,2003,108(13):1546-1551.DOI:10.1161/01.cir.0000088846.10655.e0.
[16] Tomic' M, Ljubic' S, Kastelan S. The role of inflammation and endothelial dysfunction in the pathogenesis of diabetic retinopathy[J].Coll Antropol,2013,37(Suppl 1):51-57.
[17] Madan R, Gupt B, Saluja S,et al. Coagulation profile in diabetes and its association with diabetic microvascular complications[J].J Assoc Physicians India,2010,58:481-484.

相似文献/References:

[1]郑少雄.罗格列酮和心血管风险——近期文献解读[J].国际内分泌代谢杂志,2007,(04):231.
[2]凌厉,朱本章.胰岛素类似物安全性研究进展[J].国际内分泌代谢杂志,2007,(04):234.
[3]李颖,刘东方.餐后1小时血糖升高的意义及干预[J].国际内分泌代谢杂志,2007,(04):235.
[4]崔巍,施秉银.内质网应激介导β细胞生存/死亡的研究进展[J].国际内分泌代谢杂志,2007,(04):256.
[5]杨叶虹,胡仁明.SELDI-TOF-MS技术及其在糖尿病研究中的应用[J].国际内分泌代谢杂志,2007,(04):261.
[6]高妍.针对华人糖尿病特点优化降糖方案[J].国际内分泌代谢杂志,2007,(04):269.
[7]杨志霞,郭莹辉,杨永生,等.胰岛素泵和多次皮下注射治疗糖尿病的比较[J].国际内分泌代谢杂志,2007,(04):273.
[8]周建英,马向华.胃旁路术减肥同时改善糖代谢的机制[J].国际内分泌代谢杂志,2007,(04):285.
[9]李翠柳,朱大龙.破译肠道代谢信息,驱动治疗革新[J].国际内分泌代谢杂志,2014,(06):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
　Li Cuiliu*,Zhu Dalong..Deciphering metabolic messages from the gut drives therapeutic innovation[J].International Journal of Endocrinology and Metabolism,2014,(05):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
[10]袁捷 姜云生 杜彦丽 王肃.1型糖尿病对小鼠早孕时期子宫肌层结构和细胞增殖的影响[J].国际内分泌代谢杂志,2015,(01):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]
　Yuan JieJiang YunshengDu YanliWang Su.Effects of type 1 diabetes on the muscularis structure and cell proliferation of uterine in mice during early pregnancy[J].International Journal of Endocrinology and Metabolism,2015,(05):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]

备注/Memo

备注/Memo:
通信作者:秦明照,Email: 13683371884@163.com
更新日期/Last Update: 2017-09-30